A carregar...

VS38 immunostaining in melanocytic lesions.

AIMS: To investigate the immunoreactivity of a range of melanocytic lesions, both benign and malignant, with the monoclonal antibody VS38. This was recently described as a marker of reactive/neoplastic plasma cells and, therefore, is useful in the diagnosis of plasmacytoma/myeloma and lymphomas with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shanks, J H, Banerjee, S S
Formato: Artigo
Idioma:Inglês
Publicado em: 1996
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC500398/
https://ncbi.nlm.nih.gov/pubmed/8675729
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!